Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples